List of insiders holdings for CONTEXTLOGIC INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC OrbiMed Advisors Israel II Ltd OrbiMed Israel GP II L.P. OrbiMed Genesis GP LLC Director 10% Owner | 2020-10-06 17:16:47 | 4,126,972 0 | 4,126,972 | Form 13D |
| Ioannidou Sofia Director | 2018-10-25 18:25:33 | 0 1,787,413 | 1,787,413 | Form 4 |
| Chimovits Erez Director 10% Owner | 2020-10-05 17:32:48 | 0 296,296 | 296,296 | Form 4 |
| Wilton Thomas Chief Business Officer | 2019-08-29 16:15:42 | 214,108 0 | 214,108 | Form 4 |
| Jones Cecilia Chief Financial Officer | 2022-03-03 18:05:02 | 112,000 0 | 112,000 | Form 4 |
| Paul Andrea General Counsel and Secretary | 2022-03-03 18:09:24 | 80,000 0 | 80,000 | Form 4 |
| Poole Sandra Chief Operating Officer | 2018-10-24 17:03:16 | 77,500 0 | 77,500 | Form 4/A |
| Huttner Kenneth SVP, Head of Clinical Dev. | 2020-02-13 20:00:14 | 50,000 0 | 50,000 | Form 4 |
| Falb Dean Chief Scientific Officer | 2018-10-24 17:02:31 | 30,000 0 | 30,000 | Form 4/A |
| Quick Jonathan Senior Director-Finance | 2021-01-08 17:10:03 | 29,766 0 | 29,766 | Form 3 |
| Chiang Kyle Chief Operating Officer | 2021-04-19 21:00:18 | 23,387 0 | 23,387 | Form 4 |
| Yoon Seokho Bryan Chief Admin Officer & GC | 2020-04-17 20:00:14 | 17,445 0 | 17,445 | Form 4 |
| Jaffe Matthias Chief Financial Officer | 2020-04-17 20:00:19 | 17,218 0 | 17,218 | Form 4 |
| Kariv Tomer Director | 2019-12-20 20:00:11 | 10,869 0 | 10,869 | Form 4 |
| O'Connell Daniel P Director | 2020-12-14 20:35:47 | 2,513 0 | 2,513 | Form 4 |
| Kahn Susan Director | 2022-11-17 21:02:18 | 0 0 | 0 | Form 4 |
| Kay Mark A Director | 2022-11-17 21:14:47 | 0 0 | 0 | Form 4 |
| Enyedy Mark J Director | 2022-11-17 21:13:44 | 0 0 | 0 | Form 4 |
| Nacht Mariana Chief Scientific Officer | 2022-11-17 21:12:12 | 0 0 | 0 | Form 4 |
| WYZGA MICHAEL S Director | 2022-11-17 21:11:15 | 0 0 | 0 | Form 4 |
| Chereau Frederic President, CEO | 2022-11-17 21:10:43 | 0 0 | 0 | Form 4 |
| MOSCICKI RICHARD A Director | 2022-11-17 21:09:24 | 0 0 | 0 | Form 4 |
| Goater Jeff Director | 2022-11-17 21:09:22 | 0 0 | 0 | Form 4 |
| Karydas Daphne Director | 2022-11-17 21:07:29 | 0 0 | 0 | Form 4 |
| Chen Leon Director | 2022-11-17 21:04:58 | 0 0 | 0 | Form 4 |
| Gruskin Daniel Chief Medical Officer | 2022-11-17 21:02:53 | 0 0 | 0 | Form 4 |
| Blacher Joshua Interim CFO | 2022-09-30 17:00:10 | 0 0 | 0 | Form 3 |
| Arix Bioscience plc Arix Bioscience Holdings Ltd 10% Owner | 2023-02-10 16:40:05 | 0 0 | 0 | Form 13D |